Free Trial
LON:PXS

Provexis Final Earnings Results & Report

GBX 0.90 +0.10 (+11.80%)
As of 12:25 PM Eastern

Provexis reported Final earnings on October 1, 2026. The company reported EPS of -GBX 0.02.

Earnings Announcement Details

Quarter
Final
Report Date
Time
Before Market Opens

Provexis EPS Results

Actual EPS
-GBX 0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Provexis Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Provexis Final Earnings FAQ

Provexis (LON:PXS) reported earnings of -GBX 0.02 per share for Final. The report was announced on Thursday, October 1, 2026.

Provexis Earnings Headlines

Provexis (PXS) AI Stock Analysis
Provexis PLC Full Year Sales Decline
Uranium Mine Flood That Sparked a 2006 Price Surge Returns
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.tc pixel
AIM Market Roundup: Ramsdens, Provexis, Pulsar Helium
AIM Market Roundup: Provexis, Geo Exploration, Sabien
See More Provexis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Provexis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Provexis and other key companies, straight to your email.

About Provexis

Provexis (LON:PXS), together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function. The company sells its products through distributors and online channels. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.

View Provexis Profile